London, UK, 20 August 2007: Ark Therapeutics Group plc (‘Ark’ or ‘the Company’) today announces the launch of Kerraped(R), the first therapeutic footwear to be made available on prescription, for patients with diabetic foot ulcers and other lower limb wounds. The licensing of this product was announced by the Company on 7 June 2007 and it has now been placed on the UK NHS Drug Tariff.
